Anna Radomińska‐Pandya

High Impact

Researcher

University of Arkansas for Medical Sciences

faculty

43 h-index 126 pubs 6,549 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Anna Radomińska‐Pandya's research focuses on understanding the role of cannabinoid receptors in Ewing sarcoma, a type of bone cancer. Her work investigates both natural and synthetic cannabinoids as potential therapeutic agents against this disease, exploring their effects on cell viability. This research also examines the potential mechanisms of action, including non-canonical CB receptor pathways.

Her scholarship metrics include an h-index of 43 and over 6,500 citations across 126 publications, designating her as a highly cited researcher. Radomińska‐Pandya collaborates with several colleagues at the University of Arkansas for Medical Sciences, including Alicja Urbaniak, Amal Shoeib, Azure L. Yarbrough, and Lirit N. Franks, with whom she has co-authored multiple publications.

Metrics

  • h-index: 43
  • Publications: 126
  • Citations: 6,549

Selected Publications

  • Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development (2021) DOI
  • Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics